Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

作者群：Kang YK, Terashima M, Kim YW, Boku N, Chung HC, Chen JS, Ji J, Yeh TS, Chen LT, Ryu MH, Kim JG, Omori T, Rha SY, Kim TY, Ryu KW, Sakuramoto S, Nishida Y, Fukushima N, Yamada T, Bai LY (白禮源), Hirashima Y, Hagihara S, Nakada T, Sasako M.

期刊：Lancet Gastroenterol Hepatol

出版年月：2024

圖片來源：Lancet Gastroenterol Hepatol

連結：https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00156-0/abstract